and neuroimaging features of mold infections of the CNS. Early diagnosis may allow for timely therapeutic intervention and prevention of neuro logic sequelae. Computed tomography (CT) and magnetic resonance imaging (MRI) are impor tant adjuncts in the detection of infection and in monitoring the course of therapy. Patients who are at risk or who have documented invasive mold infection of the lungs or sinuses should be evaluated with the use of neuroimaging if they have any neurologic signs or symptoms. Patients with intracranial lesions suggestive of fungal abscesses or granulomas may be candidates for stereotactic biopsy.
Two distinct patterns characterize mold infec tions of the CNS. In some patients, the disease arises by direct extension from the paranasal si nuses, eye, or middle ear, causing a single abscess or a few abscesses. 4, 5 These lesions usually occur in the frontal or temporal lobe. Other patients have hematogenous infection, which may lead to solitary or multiple small abscesses that are of ten seen at the junction of cerebral gray and white matter and in the putamen-striatal arterial distribution. Mycotic aneurysms may form and rupture, which creates the potential for hemor rhagic strokes, subarachnoid hemorrhage, and empyema formation.
Early Diagnosis
Detection of galactomannan antigen and 1,3βd glucan in cerebrospinal fluid (CSF) may be helpful in establishing the diagnosis of CNS aspergillo sis or other mold infections, such as fusariosis. 6, 7 However, because galactomannan antigen and 1,3βdglucan can also be expressed by fusari um species, its presence in CSF does not consti tute a definitive diagnosis of CNS aspergillosis 8 ; 1,3βdglucan may also be expressed by scedo sporium species and Exserohilum ros tratum. A poly merasechainreaction assay that is specific for aspergillus also may prove useful, but standard ized platforms are lacking. 9 Antifungal Therapy Table 1 outlines therapeutic interventions for mold infections of the CNS. The arsenal against these infections includes three classes of antifungal agents: polyenes (amphotericin B formulations), triazoles (voriconazole, itraconazole, and posa con azole), and echinocandins (caspofungin, mi cafungin, and anidulafungin). Voriconazole is the primary agent for the treatment of CNS as pergillosis. 12 Amphotericin B and its lipid formu lations are firstline agents for the treatment of mucormycosis. The roles of other triazoles and echinocandins in the treatment of mold infec tions of the CNS have not been well defined.
Antifungal agents vary widely in their distri bution in the CSF. 13 Voriconazole is a relatively small (349dalton), moderately lipophilic mole cule with a concentration in CSF that is approxi mately 50% of its concentration in plasma, in both animals and humans. Other antimold tri azoles, such as posaconazole and itraconazole (708 and 705 daltons, respectively), are highly lipo philic molecules with negligible concentrations in CSF. Amphotericin B (923 daltons) and its lipid formulations have relatively limited distribution in the CSF, but they do have detectable concen trations that are at or above inhibitory concentra tions within brain parenchyma. Echinocandins are larger cyclic hexapeptide molecules (1140 to 1292 daltons) with relatively low or undetectable concentrations in CSF. The administration of antifungal agents through a ventriculostomy or by the intrathecal route is not recommended because of local toxic effects and a lack of proven efficacy.
Neurosurgical Assessment and Intervention
The clinical characteristics of mold infections of the CNS warrant assessment for possible biopsy and neurosurgical intervention (Table 2) . A de finitive diagnosis almost invariably requires a biopsy, with prompt inspection of the specimen by means of wetmount preparation with calco fluor white stain, culture, and histologic analysis (with Gomori methenamine silver stain and peri odic acid-Schiff stain). In situ hybridization and immunohistochemical analysis may be helpful if cultures of biopsy specimens are negative. Be cause brain biopsies are highly invasive and may lead to neurologic deficits, they are often not fea sible; therefore, diagnosis of a mold infection of the CNS is more often made by inference based on the recovery of the pathogen from a pulmo nary or sinus source in a patient who has a CNS lesion that is radiologically consistent with a mold infection.
If the patient has a hemispheric ischemic stroke that is thought to be due to invasive fun gal infection, and if the patient's clinical condi tion -that is, coexisting conditions, coagula tion status, and overall health status -permits,
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Mold Mold Taxon and Common Features Used for Identification

Dematiaceous Mold
Aspergillus fumigatus
Calcofluor-potassium hydroxide fluorescent stain: Thin, septate hyphae of A. fumigatus are seen on this direct smear of a brain-biopsy sample.
Mucor circinelloides LPCB: The hyphae are broad, ribbonlike, and hyposeptate. Two large, round sporangia (arrows) contain many spores. Rhizoids are absent.
Scedosporium apiospermum
Front of inhibitory mold agar plate showing dark, "mouse-gray" colonies.
Scedosporium prolificans
LPCB: Hyphae are septate, and the conidiogenous cell has a swollen base (arrow) and elongated neck. Conidia with truncated bases form in clusters at the apex of the conidiogenous cell.
Fusarium species Sabouraud dextrose agar showing yellow-orange colonies.
Cladophialophora bantiana LPCB: Long, wavy chains of smooth, oval conidia (arrow) extend from the conidiophore. The brown pigment of the conidia and hyphae is apparent.
Ochroconis gallopava LPCB: The conidiophore (thin arrow) extends from a septate hypha. The two-celled, oval conidium (wide arrow) extends from the conidiophore by means of a threadlike attachment.
Exserohilum rostratum
LPCB: Dark hyphae with brown septate conidia. At both ends of the conidia, the septa are dark and conspicuous bands (arrows). Compressive and intramedullary spinal cord syndromes caused by intradural, extradural, or vertebral fungal infections necessitate prompt neurosurgical decompression, drainage, and re section. Surgical drainage or excision, tailored to the location and size of the lesion, is the first line treatment for intramedullary abscess or granuloma formations. In contrast, localized meningitis, arachnoiditis, radiculopathy, radiculo myelopathy, and anteriorspinalartery infarction are treated conservatively.
Management of Immunologic Impairments
Because innate host defenses play a critical role in protection from and eradication of mold infec tions of the CNS, the reversal of immunosup pression is essential for a successful outcome. The intrinsic immune responses within the brain, involving microglia and the complement system, appear to be inadequate as a host defense against invasive Aspergillus fumigatus. 14 In transplant re cipients, for whom reversal of immunosuppres sion may not be feasible, immunosuppressive therapy should be minimized in close coordina tion with the patient's primary care team.
Strategies that can augment the innate host response against mold infection of the CNS in clude the use of growth factors to accelerate re covery from neutropenia, provision of granulo cyte transfusions with sustained circulating neutrophils until the patient recovers from neutro penia, and discontinuation or reduction in the dose of glucocorticoids. 15, 16 The correction of metabolic acidosis and hyperglycemia is a cornerstone of the treatment of CNS mucormycosis.
Specific Pathogens
The management of mold infections of the CNS is individualized for each patient on the basis of the host response, neuroanatomical involvement, and the specific pathogen involved.
Aspergillus Species
The risk factors for CNS aspergillosis include neutropenia, systemic glucocorticoid treatment, mastoidectomy, spinal anesthesia, and paraspi nal glucocorticoid injections. 17 A. fumigatus was isolated from the index patient in the 2012 out break of fungal meningitis. 18 Focal neurologic deficits and seizures caused by stroke or mass effect are the most common clinical manifestations of CNS aspergillosis. 19 Meningeal signs are uncommon, and their pres ence is indicative of a subarachnoid hemorrhage. 20 CNS aspergillosis should be high on the list of disorders in the differential diagnosis for patients with immunosuppression and focal brain lesions, especially those with characteristic pulmonary infiltrates in whom focal neurologic deficits or focal seizures develop. Recovery of aspergillus from pulmonary lesions with the use of bron choalveolar lavage or fineneedle aspiration should be pursued when possible. An enzyme immuno assay for detection of galactomannan in serum or bronchoalveolar lavage fluid should be performed when feasible. 21 As described above, galactoman nan and 1,3βdglucan may be found in the se rum or CSF of patients with CNS aspergillosis. 6, 7 Voriconazole is the firstline treatment for CNS aspergillosis. 12 Although there are no for mal guidelines regarding therapeutic drug mon itoring in CNS aspergillosis, we recommend maintaining trough concentrations of 2 to 5 μg per milliliter in serum. Drugrelated adverse events may necessitate a reduction in dosage. Be cause voriconazole has approximately 50% pene tration through the blood-brain barrier, measure ment of concentrations in CSF is not necessary. For patients in whom voriconazole as primary therapy might have unacceptable adverse effects, liposomal amphotericin B is an alternative. 12 Monitoring of the therapeutic response of CNS aspergillosis and other mold infections of the CNS should include careful bedside evaluation and serial CT or MRI scans. The frequency of scanning should vary directly with the severity of the infection, but a reasonable interval is a intracerebral fungal abscesses. 25 Treatment with the ironchelating agent deferoxamine is a well recognized risk factor for disseminated mucor mycosis. 26 Perhaps more than any other infection, mucor mycosis of the ethmoid sinuses may involve all structures along its invasive path, including the orbit and eye, bone, and brain tissue. 25, 27 Be cause venous drainage of the ethmoid sinuses extends into the cavernous sinuses, ethmoidal mucormycosis carries a high risk of cavernous sinus thrombosis. Impairment of cranial nerves III, IV, V 1 , V 2 , and VI may be the initial signs of cavernous sinus thrombosis. Sinus opacifica tion, bony erosions, and obliteration of deep fascia planes can be detected with the use of CT and MRI. The organism may be identified by swabbing, scraping, or biopsy of an involved area to obtain samples for analysis, such as "black pus" from the nasal turbinates, fluid from a surgically drained sinus, or brain tissue. Wetmount preparations reveal ribbonlike, broad, nonseptate or hyposeptate hyphae, which are highlighted with the use of calcofluor white. Because it can be difficult to detect hyphae in frozen sections stained with hematoxylin and eosin, some institutions have introduced calcoflu orstained homog enates of intraoperative speci mens as a rapid means of determining whether Mucorales organisms are present. 28 Successful management of rhinocerebral mu cormycosis depends not only on early diagnosis but also on primary antifungal therapy with amphotericin B, reversal of host impairments -particularly diabetes mellitus, neutropenia, and glucocorticoid exposure -and timely sur gical intervention, when indicated. Posacon azole, which has in vitro activity against some isolates of Mucorales, particularly species of mucor, may have a role in followup therapy. 29 Although iron chelation with deferasirox has been shown to improve the outcome in a diabetic murine model of disseminated mucormycosis, a randomized trial of this agent did not show a benefit. 30 Adjunctive treatments, such as hyper baric oxygen, granulocyte-macrophage colony stimulating factor, and interferonγ, require fur ther study. 31 
Fusarium Species
CNS fusariosis develops predominantly in patients with prolonged neutropenia. These organisms are highly angioinvasive and cause hemorrhagic infarction with strokelike events. 32 Portals of en try include the lungs, sinuses, vascular catheters, and distinctively, periungual lesions (paronychia in patients with neutropenia). 33 Fusarium species are also most frequently associated with funge mia, multiple erythematous nodular cutaneous lesions, and septic arthritis. A positive blood cul ture growing a hyaline (i.e., colorless or lightly pigmented) mold in a patient with persistent neu tropenia is most likely to indicate the presence of fusarium. A definitive mycologic diagnosis can be rapidly established by biopsy and culture of these cutaneous lesions. As compared with other mold infections of the CNS, disseminated fusariosis is more commonly associated with bilateral endo phthalmitis, which may lead to blindness. Hema togenously disseminated fusarium infections cause chorioretinitis at a rate that is disproportionally higher than that seen with other organisms causing mold infections of the CNS. 34 Because dissemi nated fusariosis commonly causes fungemia and cutaneous lesions, early diagnosis and therapy may prevent progression to encephalitis and en dophthalmitis.
Fusarium species vary in their susceptibility to antifungal agents. 35 Voriconazole is licensed for secondline therapy; however, amphotericin B also has been used successfully. 36 A rational approach for treating patients with CNS fusariosis, pending determination of susceptibility, is the adminis tration of voriconazole plus a lipid formulation of amphotericin B.
Scedosporium Species
Scedosporium apiospermum is readily isolated from soil, polluted water, and sewage. Mold infections of the CNS caused by S. apiospermum are strongly associated with drowning events in immuno competent hosts, when the organism invades through the cribriform plate or disseminates from pneumonic foci. 37,38 Among immunocom promised patients, the features of CNS scedospo riosis resemble those of aspergillosis, including hematogenous dissemination from pulmonary lesions or by extension from the sinuses. Al though scedosporium species form branching septate hyphae that are similar to those of asper gillus, in rare cases, terminal annelloconidia are seen in tissue. Nonetheless, culture is required for a definitive diagnosis. Voriconazole is licensed as secondline therapy for S. apiospermum infections and, in the absence of alternatives, is used as initial therapy, until the in vitro susceptibility profile is available. 39 In contrast, S. prolificans is resistant experi mentally and clinically to the three major classes of antifungal agents. S. prolificans infects the CNS through hematogenous dissemination in immu nocompromised patients and through traumatic inoculation in immunocompetent hosts. 37 Unlike S. apiospermum, S. prolificans may be recovered from blood cultures. Therapy consists of surgical re section and reversal of immunosuppression.
Dematiaceous Molds
Dematiaceous fungi are a group of molds charac terized by the presence of melaninlike pigment within the cell wall that is pale brown to black. 40 These organisms can be pathogens to plants or livestock and may cause chromoblastomycosis and blackgrain mycetoma. Dematiaceous molds may also cause deeply invasive infections (phaeo hyphomycosis), including infections of the CNS. Most of the agents causing phaeohypho mycosis grow very slowly, so classic mycologic identifi cation can take 3 weeks or longer. In comparison with aspergillus, Mucorales, and fusarium, dema tiaceous molds commonly cause infections of the CNS in immunocompetent hosts. Some dematia ceous molds within a narrow geographic range cause cerebral phaeohyphomycosis. 41 Until October 2012, most known cases of CNS phaeohyphomycosis were caused by Cladophialo phora bantiana (also called Xylohypha bantiana), Rhino cladiella mackenziei, and Ochroconis gallopava (also called Dactylaria gallopava). 40 E. rostratum has since emerged as a cause of meningitis in a nationwide outbreak associated with tainted epidural glucocor ticoid injections. 42,43 Prolonged receipt of antifun gal chemotherapy, surgical resection of abscesses, and reversal of immunosuppression are mainstays of the treatment of CNS phaeohyphomycosis. Per sistence or recurrence of disease is common.
Mold infections of the CNS caused by C. bantiana are manifested as a slowly expanding, space occupying lesion causing headache, seizure, and localizing neurologic signs that simulate a brain tumor. 40 Among immunocompetent patients, CNS infection may occur in the absence of pulmonary lesions. Patients who have survived had easily resectable, encapsulated masses on CT or MRI Table S1 of the Supplementary Appendix, available with the full text of this article at NEJM.org.
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